Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.

Brown SM, Barkauskas CE, Grund B, Sharma S, Phillips AN, Leither L, Peltan ID, Lanspa M, Gilstrap DL, Mourad A, Lane K, Beitler JR, Serra AL, Garcia I, Almasri E, Fayed M, Hubel K, Harris ES, Middleton EA, Barrios MAG, Mathews KS, Goel NN, Acquah S, Mosier J, Hypes C, Salvagio Campbell E, Khan A, Hough CL, Wilson JG, Levitt JE, Duggal A, Dugar S, Goodwin AJ, Terry C, Chen P, Torbati S, Iyer N, Sandkovsky US, Johnson NJ, Robinson BRH, Matthay MA, Aggarwal NR, Douglas IS, Casey JD, Hache-Marliere M, Georges Youssef J, Nkemdirim W, Leshnower B, Awan O, Pannu S, O'Mahony DS, Manian P, Awori Hayanga JW, Wortmann GW, Tomazini BM, Miller RF, Jensen JU, Murray DD, Bickell NA, Zatakia J, Burris S, Higgs ES, Natarajan V, Dewar RL, Schechner A, Kang N, Arenas-Pinto A, Hudson F, Ginde AA, Self WH, Rogers AJ, Oldmixon CF, Morin H, Sanchez A, Weintrob AC, Cavalcanti AB, Davis-Karim A, Engen N, Denning E, Taylor Thompson B, Gelijns AC, Kan V, Davey VJ, Lundgren JD, Babiker AG, Neaton JD, Lane HC, ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group

Open source

DOI: 10.1016/s2213-2600(23)00147-9
Published: 2023 Sep
Container: The Lancet. Respiratory medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-23-00147-9,
  title = {Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.},
  author = {Brown SM and Barkauskas CE and Grund B and Sharma S and Phillips AN and Leither L and Peltan ID and Lanspa M and Gilstrap DL and Mourad A and Lane K and Beitler JR and Serra AL and Garcia I and Almasri E and Fayed M and Hubel K and Harris ES and Middleton EA and Barrios MAG and Mathews KS and Goel NN and Acquah S and Mosier J and Hypes C and Salvagio Campbell E and Khan A and Hough CL and Wilson JG and Levitt JE and Duggal A and Dugar S and Goodwin AJ and Terry C and Chen P and Torbati S and Iyer N and Sandkovsky US and Johnson NJ and Robinson BRH and Matthay MA and Aggarwal NR and Douglas IS and Casey JD and Hache-Marliere M and Georges Youssef J and Nkemdirim W and Leshnower B and Awan O and Pannu S and O'Mahony DS and Manian P and Awori Hayanga JW and Wortmann GW and Tomazini BM and Miller RF and Jensen JU and Murray DD and Bickell NA and Zatakia J and Burris S and Higgs ES and Natarajan V and Dewar RL and Schechner A and Kang N and Arenas-Pinto A and Hudson F and Ginde AA and Self WH and Rogers AJ and Oldmixon CF and Morin H and Sanchez A and Weintrob AC and Cavalcanti AB and Davis-Karim A and Engen N and Denning E and Taylor Thompson B and Gelijns AC and Kan V and Davey VJ and Lundgren JD and Babiker AG and Neaton JD and Lane HC and ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group},
  year = {2023},
  journal = {The Lancet. Respiratory medicine},
  doi = {10.1016/s2213-2600(23)00147-9},
  url = {https://doi.org/10.1016/s2213-2600(23)00147-9}
}

RIS

TY  - JOUR
TI  - Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
AU  - Brown SM
AU  - Barkauskas CE
AU  - Grund B
AU  - Sharma S
AU  - Phillips AN
AU  - Leither L
AU  - Peltan ID
AU  - Lanspa M
AU  - Gilstrap DL
AU  - Mourad A
AU  - Lane K
AU  - Beitler JR
AU  - Serra AL
AU  - Garcia I
AU  - Almasri E
AU  - Fayed M
AU  - Hubel K
AU  - Harris ES
AU  - Middleton EA
AU  - Barrios MAG
AU  - Mathews KS
AU  - Goel NN
AU  - Acquah S
AU  - Mosier J
AU  - Hypes C
AU  - Salvagio Campbell E
AU  - Khan A
AU  - Hough CL
AU  - Wilson JG
AU  - Levitt JE
AU  - Duggal A
AU  - Dugar S
AU  - Goodwin AJ
AU  - Terry C
AU  - Chen P
AU  - Torbati S
AU  - Iyer N
AU  - Sandkovsky US
AU  - Johnson NJ
AU  - Robinson BRH
AU  - Matthay MA
AU  - Aggarwal NR
AU  - Douglas IS
AU  - Casey JD
AU  - Hache-Marliere M
AU  - Georges Youssef J
AU  - Nkemdirim W
AU  - Leshnower B
AU  - Awan O
AU  - Pannu S
AU  - O'Mahony DS
AU  - Manian P
AU  - Awori Hayanga JW
AU  - Wortmann GW
AU  - Tomazini BM
AU  - Miller RF
AU  - Jensen JU
AU  - Murray DD
AU  - Bickell NA
AU  - Zatakia J
AU  - Burris S
AU  - Higgs ES
AU  - Natarajan V
AU  - Dewar RL
AU  - Schechner A
AU  - Kang N
AU  - Arenas-Pinto A
AU  - Hudson F
AU  - Ginde AA
AU  - Self WH
AU  - Rogers AJ
AU  - Oldmixon CF
AU  - Morin H
AU  - Sanchez A
AU  - Weintrob AC
AU  - Cavalcanti AB
AU  - Davis-Karim A
AU  - Engen N
AU  - Denning E
AU  - Taylor Thompson B
AU  - Gelijns AC
AU  - Kan V
AU  - Davey VJ
AU  - Lundgren JD
AU  - Babiker AG
AU  - Neaton JD
AU  - Lane HC
AU  - ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TESICO) Study Group
PY  - 2023
JO  - The Lancet. Respiratory medicine
DO  - 10.1016/s2213-2600(23)00147-9
UR  - https://doi.org/10.1016/s2213-2600(23)00147-9
ER  -

APA

SM, B., CE, B., B, G., S, S., AN, P., L, L., ID, P., M, L., DL, G., A, M., K, L., JR, B., AL, S., I, G., E, A., M, F., K, H., ES, H., EA, M., MAG, B., KS, M., NN, G., S, A., J, M., C, H., E, S. C., A, K., CL, H., JG, W., JE, L., A, D., S, D., AJ, G., C, T., P, C., S, T., N, I., US, S., NJ, J., BRH, R., MA, M., NR, A., IS, D., JD, C., M, H., J, G. Y., W, N., B, L., O, A., S, P., DS, O., P, M., JW, A. H., GW, W., BM, T., RF, M., JU, J., DD, M., NA, B., J, Z., S, B., ES, H., V, N., RL, D., A, S., N, K., A, A., F, H., AA, G., WH, S., AJ, R., CF, O., H, M., A, S., AC, W., AB, C., A, D., N, E., E, D., B, T. T., AC, G., V, K., VJ, D., JD, L., AG, B., JD, N., HC, L., & Group, A. F. S. I. I. W. C. (. S. (2023). Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.. The Lancet. Respiratory medicine. https://doi.org/10.1016/s2213-2600(23)00147-9

Source records

pubmed · retrieved 2026-09-26T00:39:11.553Z